The severity of the disorder manifests from mild (SMA type 4) to severe (SMA type 1), and the clinical severity depends on the number of copies of the similar but less-stable SMN2-gene [5,6,7]. The gene discussed is SMN2; the disease is spinal muscular atrophy, type 1.